The International Waldenstrom’s Macroglobulinemia Foundation (IWMF)
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a patient-founded and patient-led non-profit organization, comprised of 99% volunteers and represents 32,000 Waldenstrom’s patients worldwide! They want you to know with the IWMF, you are never alone and anyone can become a member. As the IWMF strives to support the lives of those living with this rare cancer, the organization offers critical services to achieve that end.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Resources & Support
Patient Worthy Posts on Waldenstrom Macroglobulinemia
Waldenström’s Macroglobulinemia: The Latest in Signs, Symptoms, and Diagnosis
According to an article from MedPage Today, Waldenström’s macroglobulinemia (WM) is a rare form of lymphoma. Only about 1,500 cases are diagnosed each year in
New Treatment for WM Could Soon be Approved in the EU
According to a press release from Business Wire, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recently issued a positive
Second-Ever Therapy for Waldenström’s Macroglobulinemia is Now FDA Approved
The FDA has just announced their approval of zanubrutinib (Brukinsa) as a therapeutic option for Waldenström’s macroglobulinemia. This approval was given based on the ASPEN
ICYMI: Country Singer Ashley Monroe Diagnosed with WM
Ashley Monroe is an extremely talented singer-songwriter who hails from Tennessee. Over the years, Ashley has grown her music career alone and as part of
IWMF Webinar: ASCO 2021 Advances in WM
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) recently held the latest webinar in its Global Education series on July 9, 2021. This webinar was a summary
IWMF Webinar Covers WM Peripheral Neuropathy
On May 4th The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) held another webinar in its 2021 IWMF Global Education series titled Peripheral Neuropathy: No Easy Feat.
